Safety and Efficacy of Pitolisant on Excessive Daytime Sleepiness and Other Non-Muscular Symptoms in Patients With Myotonic Dystrophy Type 1

Conditions:   Myotonic Dystrophy 1;   Excessive Daytime Sleepiness Interventions:   Drug: Pitolisant Oral Tablet;   Drug: Placebo oral tablet Sponsor:   Harmony Biosciences, LLC Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials